Shattuck Labs (STTK) Stock Insights
$582.61M
Market Cap
-10.76
P/E
—
Forward P/E
—
Score
STTK price $5.80 +0.04 +0.61%
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| 22442000 | 9887000 | 9934000 | 30017000 | 652000 | 1657000 | 5721000 | 1000000 |
Shattuck Labs, Inc. operates as a biotechnology firm based in the United States, currently at the clinical development stage. Its core mission is to create innovative therapeutics designed to combat both cancer and autoimmune diseases. The company's leading experimental compound, SL-172154, is presently undergoing Phase 1 clinical assessment for the treatment of ovarian, fallopian tube, and peritoneal cancers…
STTK fair value Not meaningful. Price $5.80.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Not meaningful
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-10 | — | -0.10 | — | 33.33K |
| 2026-08-11 | -0.12 | -0.12 | — | — |
| 2026-05-07 | -0.13 | -0.14 | — | — |
| 2026-03-05 | -0.12 | -0.12 | — | 250.00K |
| 2025-11-06 | -0.14 | -0.15 | 1.00M | 166.67K |
| 2025-08-14 | -0.24 | -0.25 | — | — |
| 2025-05-01 | -0.27 | -0.29 | — | — |
| 2025-03-27 | -0.37 | -0.38 | 14.49M | 799.40K |
| 2024-11-14 | -0.33 | -0.41 | 3.00M | 250.00K |
| 2024-08-01 | -0.42 | -0.41 | 1.61M | 580.00K |
| 2024-05-02 | -0.37 | -0.47 | 1.11M | 304.67K |
| 2024-02-29 | -0.41 | -0.51 | 714.00K | 200.00K |
| 2023-11-09 | -0.65 | -0.52 | 686.00K | 180.00K |
| 2023-08-10 | -0.50 | -0.52 | 200.00K | 100.00K |
| 2023-05-09 | -0.49 | -0.61 | 57.00K | 80.00K |
| 2023-02-23 | -0.60 | -0.62 | 390.00K | 45.00K |
| 2022-11-08 | -0.58 | -0.68 | 212.00K | — |
| 2022-08-11 | -0.65 | -0.61 | 50.00K | — |
| 2022-05-12 | -0.58 | -0.55 | — | 575.00K |
| 2022-03-15 | 0.18 | -0.43 | 30.08M | 1.98M |
| 2021-11-09 | -0.41 | -0.44 | 1.90M | 1.95M |
| 2021-08-11 | -0.56 | -0.34 | -4.23M | -3.70M |
| 2021-05-10 | -0.28 | -0.39 | 2.27M | 2.91M |
| 2021-03-15 | -0.31 | -0.39 | 1.34M | — |
| 2020-11-13 | -1.54 | -0.34 | 2.44M | — |
| 2020-10-13 | -0.16 | — | 3.18M | — |
| 2020-03-31 | -0.34 | — | 2.98M | — |
| 2019-12-31 | -0.39 | — | 2.82M | — |
| 2019-09-30 | -0.38 | — | 1.78M | — |
| 2019-06-30 | -0.62 | — | 2.64M | — |
| 2019-03-31 | -0.62 | — | 2.64M | — |
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-07-06 | Shukla Abhinav A. | Buy | 12.15K | $3.57 | 43.39K |
| 2026-07-06 | Shukla Abhinav A. | Sell | 12.15K | $3.57 | 43.39K |
| 2026-07-02 | Shukla Abhinav A. | Buy | 410 | $3.57 | 1.46K |
| 2026-07-02 | Shukla Abhinav A. | Sell | 410 | $7.01 | 2.87K |
| 2026-07-02 | Shukla Abhinav A. | Sell | 410 | $3.57 | 1.46K |
| 2026-07-01 | Shukla Abhinav A. | Buy | 100 | $3.57 | 357 |
| 2026-07-01 | Shukla Abhinav A. | Sell | 100 | $7.07 | 707 |
| 2026-07-01 | Shukla Abhinav A. | Sell | 100 | $3.57 | 357 |
| 2026-06-30 | Shukla Abhinav A. | Buy | 23.36K | $3.57 | 83.41K |
| 2026-06-30 | Shukla Abhinav A. | Sell | 23.36K | $7.08 | 165.42K |
| 2026-06-30 | Shukla Abhinav A. | Sell | 23.36K | $3.57 | 83.41K |
| 2026-06-30 | Pandite Arundathy N. | Sell | 30.00K | $7.01 | 210.30K |
| 2026-06-11 | Ashiya Mona | Buy | 1.04M | $0.00 | 104 |
| 2026-06-11 | Ashiya Mona | Buy | 208.33K | $0.00 | 21 |
| 2026-06-11 | ORBIMED ADVISORS LLC | Buy | 1.04M | $0.00 | 104 |
| 2026-06-11 | ORBIMED ADVISORS LLC | Buy | 208.33K | $0.00 | 21 |
| 2026-06-09 | SIEGALL CLAY B | Buy | 62.50K | $4.00 | 250.00K |
| 2026-06-08 | ORBIMED ADVISORS LLC | Buy | 15.37M | $0.00 | 1.54K |
| 2026-06-08 | ORBIMED ADVISORS LLC | Buy | 3.07M | $0.00 | 307 |
| 2026-06-08 | ORBIMED ADVISORS LLC | Sell | 3.07M | $1.08 | 3.33M |
| 2026-06-08 | Ashiya Mona | Buy | 15.37M | $0.00 | 1.54K |
| 2026-06-08 | Ashiya Mona | Buy | 3.07M | $0.00 | 307 |
| 2026-06-08 | Ashiya Mona | Sell | 3.07M | $1.08 | 3.33M |
| 2026-05-29 | Baker Daniel G. | Buy | 81.00K | $5.95 | 481.95K |
| 2026-05-29 | Golumbeski George | Buy | 81.00K | $5.95 | 481.95K |
| 2026-05-29 | Gibson Neil W | Buy | 81.00K | $5.95 | 481.95K |
| 2026-05-29 | Ashiya Mona | Buy | 81.00K | $5.95 | 481.95K |
| 2026-05-29 | SIEGALL CLAY B | Buy | 81.00K | $5.95 | 481.95K |
| 2026-05-29 | Boudreau Helen M | Buy | 81.00K | $5.95 | 481.95K |
| 2026-05-22 | SIEGALL CLAY B | Buy | 128.05K | $1.08 | 138.89K |
| 2026-05-22 | SIEGALL CLAY B | Sell | 128.05K | $1.08 | 138.89K |
| 2026-05-21 | Shukla Abhinav A. | Buy | 5.12K | $1.08 | 5.56K |
| 2026-05-21 | Shukla Abhinav A. | Sell | 5.12K | $1.08 | 5.56K |
| 2026-05-15 | Stout Stephen | Buy | 12.80K | $1.08 | 13.89K |
| 2026-05-15 | Stout Stephen | Sell | 12.80K | $1.08 | 13.89K |
| 2026-05-12 | Neill Andrew R | Buy | 64.03K | $1.08 | 69.44K |
| 2026-05-12 | Neill Andrew R | Sell | 64.03K | $1.08 | 69.44K |
| 2026-05-12 | Shukla Abhinav A. | Buy | 2.03K | $3.57 | 7.25K |
| 2026-05-12 | Shukla Abhinav A. | Sell | 2.03K | $7.01 | 14.24K |
| 2026-05-12 | Shukla Abhinav A. | Sell | 2.03K | $3.57 | 7.25K |
| 2026-05-12 | Pandite Arundathy N. | Sell | 30.00K | $6.61 | 198.30K |
| 2026-05-12 | Schreiber Taylor | Buy | 25.61K | $1.08 | 27.78K |
| 2026-05-12 | Schreiber Taylor | Sell | 25.61K | $1.08 | 27.78K |
| 2026-05-10 | Stout Stephen | Sell | 968 | $6.85 | 6.63K |
| 2026-01-25 | Pandite Arundathy N. | Sell | 3.19K | $4.15 | 13.26K |
| 2026-01-25 | Stout Stephen | Sell | 593 | $4.15 | 2.46K |
| 2026-01-25 | DeYoung Casi | Sell | 2.29K | $4.15 | 9.49K |
| 2026-01-25 | Neill Andrew R | Sell | 2.59K | $4.15 | 10.74K |
| 2026-01-10 | Stout Stephen | Buy | 351.40K | $4.75 | 1.67M |
| 2026-01-10 | Stout Stephen | Sell | 4.15K | $4.75 | 19.73K |
| 2026-01-10 | DeYoung Casi | Buy | 381.60K | $4.75 | 1.81M |
| 2026-01-10 | DeYoung Casi | Sell | 5.70K | $4.75 | 27.07K |
| 2026-01-10 | Shukla Abhinav A. | Buy | 315.50K | $4.75 | 1.50M |
| 2026-01-10 | Pandite Arundathy N. | Buy | 487.80K | $4.75 | 2.32M |
| 2026-01-10 | Pandite Arundathy N. | Sell | 6.85K | $4.75 | 32.54K |
| 2026-01-10 | Neill Andrew R | Buy | 549.80K | $4.75 | 2.61M |
| 2026-01-10 | Neill Andrew R | Sell | 6.66K | $4.75 | 31.64K |
| 2026-01-10 | Schreiber Taylor | Buy | 1.55M | $4.75 | 7.35M |
| 2025-08-28 | Ashiya Mona | Buy | 66.30K | $0.99 | 65.64K |
| 2025-08-28 | Baker Daniel G. | Buy | 66.30K | $0.99 | 65.64K |
| 2025-08-25 | ORBIMED ADVISORS LLC | Buy | 15.37M | $1.08 | 16.67M |
| 2025-08-25 | ORBIMED ADVISORS LLC | Buy | 10.11M | $0.00 | 1.01K |
| 2025-08-25 | ORBIMED ADVISORS LLC | Buy | 5.26M | $0.87 | 4.56M |
| 2025-08-25 | ORBIMED ADVISORS LLC | Buy | 3.07M | $1.08 | 3.33M |
| 2025-08-25 | ORBIMED ADVISORS LLC | Buy | 2.02M | $0.00 | 202 |
| 2025-08-25 | ORBIMED ADVISORS LLC | Buy | 1.05M | $0.87 | 911.97K |
| 2025-08-25 | Ashiya Mona | Buy | 15.37M | $1.08 | 16.67M |
| 2025-08-25 | Ashiya Mona | Buy | 10.11M | $0.00 | 1.01K |
| 2025-08-25 | Ashiya Mona | Buy | 5.26M | $0.87 | 4.56M |
| 2025-08-25 | Ashiya Mona | Buy | 3.07M | $1.08 | 3.33M |
| 2025-08-25 | Ashiya Mona | Buy | 2.02M | $0.00 | 202 |
| 2025-08-25 | Ashiya Mona | Buy | 1.05M | $0.87 | 911.97K |
| 2025-08-25 | ORBIMED ADVISORS LLC | Other | 0 | — | — |
| 2025-08-25 | Baker Daniel G. | Other | 0 | — | — |
| 2025-08-25 | Ashiya Mona | Other | 0 | — | — |
| 2025-08-25 | Stout Stephen | Buy | 12.80K | $0.87 | 11.11K |
| 2025-08-25 | Stout Stephen | Buy | 12.80K | $1.08 | 13.89K |
| 2025-08-25 | Neill Andrew R | Buy | 64.03K | $0.87 | 55.56K |
| 2025-08-25 | Neill Andrew R | Buy | 64.03K | $1.08 | 69.44K |
| 2025-08-25 | SIEGALL CLAY B | Buy | 128.05K | $0.87 | 111.11K |
| 2025-08-25 | SIEGALL CLAY B | Buy | 128.05K | $1.08 | 138.89K |
| 2025-08-25 | Schreiber Taylor | Buy | 25.61K | $0.87 | 22.22K |
| 2025-08-25 | Shukla Abhinav A. | Buy | 5.12K | $0.87 | 4.44K |
| 2025-08-25 | Schreiber Taylor | Buy | 25.61K | $1.08 | 27.78K |
| 2025-08-25 | Shukla Abhinav A. | Buy | 5.12K | $1.08 | 5.56K |
| 2025-08-25 | Redmile Group, LLC | Buy | 4.10M | $0.00 | 410 |
| 2025-08-25 | Redmile Group, LLC | Buy | 4.10M | $1.08 | 4.44M |
| 2025-07-14 | Lee Michael Stewart | Buy | 33.15K | $0.82 | 27.18K |
| 2025-07-14 | Redmile Group, LLC | Buy | 33.15K | $0.82 | 27.18K |
| 2025-07-14 | SIEGALL CLAY B | Buy | 33.15K | $0.82 | 27.18K |
| 2025-07-14 | Sasser Amy Kate | Buy | 33.15K | $0.82 | 27.18K |
| 2025-07-14 | Golumbeski George | Buy | 33.15K | $0.82 | 27.18K |
| 2025-07-14 | Gibson Neil W | Buy | 33.15K | $0.82 | 27.18K |
| 2025-07-14 | Brownstein Carrie | Buy | 33.15K | $0.82 | 27.18K |
| 2025-07-14 | Brous Tyler | Buy | 33.15K | $0.82 | 27.18K |
| 2025-07-14 | Boudreau Helen M | Buy | 33.15K | $0.82 | 27.18K |
| 2025-01-28 | Shukla Abhinav A. | Buy | 165.20K | $1.18 | 194.94K |
| 2025-01-28 | DeYoung Casi | Buy | 194.30K | $1.18 | 229.27K |
| 2025-01-28 | Pandite Arundathy N. | Buy | 206.20K | $1.18 | 243.32K |
| 2025-01-28 | Stout Stephen | Buy | 177.00K | $1.18 | 208.86K |
Latest filed quarter: Q2 2026.
Institutions holding: 107, holders +24 vs prior quarter. Ownership 64.70%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 13.43M | 3.57M | +36.16% | 93.22M |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 8.12M | 3.48M | +74.86% | 56.37M |
| REDMILE GROUP, LLC | 6.89M | 1.35M | +24.41% | 47.83M |
| ORBIMED ADVISORS LLC | 6.31M | 0 | 0.00% | 43.76M |
| PROSIGHT MANAGEMENT, LP | 5.96M | 953.44K | +19.05% | 41.35M |
| BLACKROCK, INC. | 3.94M | 3.43M | +670.51% | 27.31M |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 3.75M | 3.75M | New | 26.02M |
| NEXTBIO CAPITAL MANAGEMENT LP | 3.73M | 577.44K | +18.33% | 25.87M |
| DEEP TRACK CAPITAL, LP | 3.71M | 3.71M | New | 25.72M |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.21M | 930.69K | +40.87% | 22.26M |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2.64M | 858.29K | +48.14% | 18.33M |
| PINNACLE ASSOCIATES LTD | 1.87M | 503.22K | +36.78% | 12.99M |
| WELLINGTON MANAGEMENT GROUP LLP | 1.77M | 1.77M | New | 12.27M |
| GEODE CAPITAL MANAGEMENT, LLC | 1.58M | 939.05K | +145.43% | 11.00M |
| CLARK ESTATES INC/NY | 1.43M | -45.48K | -3.08% | 9.93M |
| ABERDEEN GROUP PLC | 1.41M | 246.53K | +21.27% | 9.76M |
| POINT72 ASSET MANAGEMENT, L.P. | 1.17M | 139.68K | +13.55% | 8.12M |
| 683 CAPITAL MANAGEMENT, LLC | 1.16M | 357.22K | +44.65% | 8.03M |
| STATE STREET CORP | 1.03M | 762.63K | +289.13% | 7.12M |
| BOXER CAPITAL MANAGEMENT, LLC | 1.00M | 1.00M | New | 6.94M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 946.99K | 946.99K | New | 6.57M |
| RENAISSANCE TECHNOLOGIES LLC | 743.76K | 139.26K | +23.04% | 5.16M |
| GOLDMAN SACHS GROUP INC | 593.32K | 401.88K | +209.92% | 4.12M |
| TD ASSET MANAGEMENT INC | 558.88K | 176.23K | +46.05% | 3.88M |
| NORTHERN TRUST CORP | 520.32K | 394.25K | +312.75% | 3.61M |
Insights · Dividends · Forecast · Financials · Learn
$582.61M
Market Cap
-10.76
P/E
—
Forward P/E
—
Score